Sulfasalazine and dermatitis herpetiformis

Australasian Journal of Dermatology

Volumn 46, Issue 2, 2005, Pages 101-103

  Willsteed, Elizabeth ^a,b   Lee, Michael ^a   Wong, Li Chuen ^a   Cooper, Alan ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b NONE   (Australia)

Author keywords

Dapsone; Gluten free diet; Sulfapyridine

Indexed keywords

BETAMETHASONE DIPROPIONATE; CIMETIDINE; COLCHICINE; CYCLOSPORIN; DAPSONE; HEMOGLOBIN; MINOCYCLINE; NICOTINAMIDE; PREDNISONE; SALAZOSULFAPYRIDINE; TETRACYCLINE;

ADULT; AGED; ARTICLE; BULLOUS DERMATITIS; CASE REPORT; CLINICAL FEATURE; DERMATITIS HERPETIFORMIS; DIZZINESS; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG METABOLISM; DRUG RESPONSE; FEMALE; GLUTEN FREE DIET; HEADACHE; HEMOGLOBINOPATHY; HUMAN; LIVER PAIN; MALE; NAUSEA; PRURITUS; SYMPTOM; SYSTEMIC DISEASE; TREATMENT FAILURE;

ADMINISTRATION, ORAL; ADULT; AGED; ANEMIA, PERNICIOUS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DERMATITIS HERPETIFORMIS; DIABETES MELLITUS, TYPE 1; DIAGNOSIS, DIFFERENTIAL; DIET, PROTEIN-RESTRICTED; FEMALE; HUMANS; MALE; MIDDLE AGED; SULFASALAZINE;

EID: 18944378096     PISSN: 00048380     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2005.00152.x     Document Type: Article

References (12)

1. Goldstein BG, Graham Smith J Jr. Sulfasalazine in dermatitis herpetiformis [Letter]. J. Am. Acad. Dermatol. 1990; 22: 697.
2. Lowney ED. Use of sulfasalazine in dermatitis herpetiformis in young people [Letter]. Arch. Dermatol. 1978; 114: 1553.
3. Lambert ID, Collet K, Foucher JL, Escallier E, Dalae S. Dermatitis herpetiformis associated with ulcerative colitis. Clin. Exp. Dermatol. 1991; 16: 458-9.
4. Klotz U. Clinical pharmacokinetics of sulfasalazine, its metabolites and other pro-drugs of 5 aminosalicylic acid. Clin. Pharmacokinet. 1985; 10: 285-302.
5. Hall RP. Dapsone. In: Wolverton SE (ed.). Comprehensive Dermatologic Drug Therapy. Philadelphia: WB Saunders Company, 2001; 230-50.
6. Stenson WE, Lobos E. Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils. J. Clin. Invest. 1982; 69: 494-7.
7. Stendahl O, Molin L, Lindroth M. Granulocyte mediated release of histamine from mast cells: effect of myeloperoxidase and its inhibition by anti inflammatory sulphones. Int. Arch. Allergy Appl. Immunol. 1983; 70: 277-84.
8. Costello M. Dermatitis herpetiformis treated with sulfapyridine. Arch. Dermatol. Syphil. 1940; 41: 134.
9. Kruizinga EE, Hamminga H. Treatment of dermatitis herpetiformis with diaminodiphenylsulphone (DDS). Dermatologica 1953; 106: 386-94.
10. Gupta AK, Ellis CN, Siegel M, Voorhees JJ. Sulfasalazine: a potential psoriasis therapy? J. Am. Acad. Dermatol. 1989; 20: 797-800.
11. Ellis CN, Brown MF, Voorhees JJ. Sulfasalazine for alopecia areata. J. Am. Acad. Dermatol. 2002; 46: 541-5.
12. Carroll PR (ed.). Section 1: alimentary system. MIMS Annual. 27th edn. Sydney: Medi Media Australia Ply Ltd, 2003; 1-39-1-41.